本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CRISPR Therapeutics AG

60.90
+3.836.70%
盤後60.09-0.8099-1.33%19:59 EDT
成交量:208.37萬
成交額:1.27億
市值:58.89億
市盈率:-12.80
高:61.55
開:57.93
低:57.51
收:57.08
52周最高:78.48
52周最低:44.12
股本:9,669.26萬
流通股本:9,316.62萬
量比:0.89
換手率:2.24%
股息:- -
股息率:- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
淨資產收益率:-26.09%
總資產收益率:-14.20%
市淨率:3.37
市盈率(LYR):-9.41

資料載入中...

2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/10

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]